Literature DB >> 15907253

Treatment of postherpetic neuralgia.

T J Nurmikko1, M Haanpää.   

Abstract

Postherpetic neuralgia (PHN) remains one of the most troublesome common chronic neuropathic pain conditions. Many controlled trials have been published showing good efficacy and reasonable tolerability. These include gabapentinoids, opioids, tricyclic antidepressants, and topical lidocaine and capsaicin. Combination therapies are possible, but have not been proven, and long-term follow-up is limited. Only few case series exist for surgical and other invasive therapies and their role remains uncertain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907253     DOI: 10.1007/s11916-005-0057-9

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  52 in total

Review 1.  The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia.

Authors:  Christopher L Wu; Ann Marsh; Robert H Dworkin
Journal:  Pain       Date:  2000-08       Impact factor: 6.961

2.  The prognosis with postherpetic neuralgia.

Authors:  Peter N C Watson; Verna R Watt; Mary Chipman; Nicholas Birkett; Ramon J Evans
Journal:  Pain       Date:  1991-08       Impact factor: 6.961

3.  Somatosensory findings in postherpetic neuralgia.

Authors:  T Nurmikko; D Bowsher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

4.  Topical capsaicin treatment of chronic postherpetic neuralgia.

Authors:  J E Bernstein; N J Korman; D R Bickers; M V Dahl; L E Millikan
Journal:  J Am Acad Dermatol       Date:  1989-08       Impact factor: 11.527

5.  The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK.

Authors:  B K MacDonald; O C Cockerell; J W Sander; S D Shorvon
Journal:  Brain       Date:  2000-04       Impact factor: 13.501

6.  Capsaicin evoked pain and allodynia in post-herpetic neuralgia.

Authors:  Karin L Petersen; Howard L Fields; Jannick Brennum; Paola Sandroni; Michael C Rowbotham
Journal:  Pain       Date:  2000-11       Impact factor: 6.961

7.  Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia.

Authors:  A Kikuchi; N Kotani; T Sato; K Takamura; I Sakai; A Matsuki
Journal:  Reg Anesth Pain Med       Date:  1999 Jul-Aug       Impact factor: 6.288

8.  Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia.

Authors:  S B Graff-Radford; L R Shaw; B N Naliboff
Journal:  Clin J Pain       Date:  2000-09       Impact factor: 3.442

9.  Intrathecal methylprednisolone for intractable postherpetic neuralgia.

Authors:  N Kotani; T Kushikata; H Hashimoto; F Kimura; M Muraoka; M Yodono; M Asai; A Matsuki
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

10.  Electrical stimulation of the trigeminal tract in chronic, intractable facial neuralgia.

Authors:  J Holsheimer
Journal:  Arch Physiol Biochem       Date:  2001-10       Impact factor: 4.076

View more
  1 in total

1.  Population pharmacokinetic model of the pregabalin-sildenafil interaction in rats: application of simulation to preclinical PK-PD study design.

Authors:  Gregor Bender; James Gosset; Jeff Florian; Keith Tan; Mark Field; Scott Marshall; Joost DeJongh; Robert Bies; Meindert Danhof
Journal:  Pharm Res       Date:  2009-08-11       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.